2022
DOI: 10.1177/03000605221129558
|View full text |Cite
|
Sign up to set email alerts
|

Clostridium subterminale infection in a patient with diffuse large B-cell lymphoma and haemophagocytic syndrome: A case report and literature review

Abstract: Although uncommon, infection caused by Clostridium subterminale may be life threatening particularly in immunocompromised patients. We report here a rare presentation of a patient with diffuse large B-cell lymphoma and haemophagocytic syndrome associated with C. subterminale bacteraemia. The management of the patient is described as well as a review of medical literature. Infection by Clostridium species, including C. subterminale, should be considered in a febrile patient with a haematologic malignancy. The c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…HPS treatment is divided into the following two aspects: First, induction and remission therapy, which is to primarily control excessive inflammatory symptoms; second, etiological treatment, which focuses on correcting underlying immune deficiencies and controlling the primary disorder[ 10 ]. In this case, following ganciclovir antiviral treatment combined with meropenem antibacterial therapy and methylprednisolone inhibition to inflammatory response, gamma globulin enhanced immunotherapy, granulocyte levels increased, transaminase levels decreased, and the symptoms were relieved.…”
Section: Discussionmentioning
confidence: 99%
“…HPS treatment is divided into the following two aspects: First, induction and remission therapy, which is to primarily control excessive inflammatory symptoms; second, etiological treatment, which focuses on correcting underlying immune deficiencies and controlling the primary disorder[ 10 ]. In this case, following ganciclovir antiviral treatment combined with meropenem antibacterial therapy and methylprednisolone inhibition to inflammatory response, gamma globulin enhanced immunotherapy, granulocyte levels increased, transaminase levels decreased, and the symptoms were relieved.…”
Section: Discussionmentioning
confidence: 99%